IDEXX Laboratories, Inc.
IDXX
$579.85
$2.730.47%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 19.33% | 18.61% | 16.56% | 3.28% | 5.07% |
| Total Depreciation and Amortization | 11.73% | 11.27% | 13.95% | 15.12% | 13.08% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 360.60% | 2,279.19% | 510.04% | 142.51% | 134.01% |
| Change in Net Operating Assets | -70.76% | -206.27% | -3,040.76% | -35.17% | -83.96% |
| Cash from Operations | 27.21% | 18.68% | -6.54% | 5.12% | 2.48% |
| Capital Expenditure | -3.10% | -0.22% | 6.72% | 2.99% | 9.51% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 100.00% | 100.40% | 100.40% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -22.41% | -818.82% | -201.97% | -207.50% | -212.76% |
| Cash from Investing | 34.20% | 25.15% | 34.16% | 32.67% | -65.31% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -471.18% | 31.08% | -104.52% | 70.56% | 81.44% |
| Issuance of Common Stock | 109.84% | 108.49% | -14.77% | -44.11% | -5.40% |
| Repurchase of Common Stock | -44.44% | -93.03% | -167.93% | -359.27% | -934.94% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -32.67% | -39.47% | -104.27% | -141.90% | -98.66% |
| Foreign Exchange rate Adjustments | 217.52% | -70.30% | 336.48% | -219.25% | -548.35% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 34.69% | -335.69% | -188.18% | -181.61% | -148.53% |